KEZAR LIFE SCIENCES, INC.

Analyst Reco. Kezar Life Sciences, Inc.

Equities

KZR

US49372L1008

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
0.79 ^USD	+0.30%		-8.43%	-16.61%

Mar. 14	Kezar Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 14	Kezar Life Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wells Fargo Adjusts Price Target on Kezar Life Sciences to $2 From $4, Maintains Equal-Weight Rating	Nov. 14	MT
JonesTrading Downgrades Kezar Life Sciences to Hold From Buy	23-10-05	MT
HC Wainwright Raises Kezar Life Sciences Price Target to $20 From $18, Maintains Buy Rating	23-09-25	MT
Wells Fargo Downgrades Kezar Life Sciences to Equalweight From Overweight	23-08-11	MT
HC Wainwright Adjusts Price Target on Kezar Life Sciences to $18 From $19, Maintains Buy Rating	23-08-11	MT
HC Wainwright Adjusts Price Target on Kezar Life Sciences to $19 From $21, Keeps Buy Rating	23-05-12	MT
Wells Fargo Trims Kezar Life Sciences Price Target to $13 From $14, Maintains Overweight Rating	23-05-12	MT
William Blair Downgrades Kezar Life Sciences to Market Perform From Outperform	23-03-16	MT
Wells Fargo Cuts Price Target on Kezar Life Sciences to $14 From $17, Maintains Overweight Rating	23-01-03	MT
Wells Fargo Adjusts Kezar Life Sciences Price Target to $17 From $13, Maintains Overweight Rating	22-06-28	MT
Wells Fargo Adjusts Kezar Life Sciences' Price Target to $14 from $19, Keeps Overweight Rating	22-05-04	MT
Wall Street Set for Higher Open Ahead of Fed Funds Rate Announcement, ISM's Services Index	22-05-04	MT
HC Wainwright Adjusts Kezar Life Sciences' Price Target to $22 From $20, Keeps Buy Rating	22-03-18	MT
Wells Fargo Starts Kezar Life Sciences at Overweight With $19 Price Target	21-12-08	MT
HC Wainwright Adjusts Price Target on Kezar Life Sciences to $20 from $12, Keeps Buy Rating	21-11-16	MT
KEZAR LIFE SCIENCES : JonesTrading Starts Kezar Life Sciences at Buy With $14 Price Target	21-07-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer